Mullin departs Medium’s OneZero – Speaking Biz Information

Emily Mullin, who had been reporting on biotech for Medium’s OneZero publication, is amongst those that have taken its buyout supply. “I’m grateful to have had the chance to pursue significant tales about biotechnology and society over the previous two years,” she wrote on Twitter. Emily Mullin Mullen was beforehand a contract author who has


Emily Mullin, who had been reporting on biotech for Medium’s OneZero publication, is amongst those that have taken its buyout supply.

“I’m grateful to have had the chance to pursue significant tales about biotechnology and society over the previous two years,” she wrote on Twitter.

Emily Mullin

Mullen was beforehand a contract author who has had bylines in The Washington Submit, The Wall Avenue JournalScientific American, Nationwide Geographic, The Atlantic, Science, QuartzPacific Commonplace, and The Baltimore Solar, amongst others.

Her areas of curiosity embrace gene remedy, CRISPR, shopper genetics, reproductive know-how, mind implants, regenerative medication, biohacking, and AI in medication.

She has additionally labored as affiliate editor for biomedicine at MIT Expertise Assessment, the place she earned a Newsbrief Award from the D.C. Science Writers Affiliation.

She earned her bachelor’s diploma in journalism at Ohio College and a grasp’s in science writing from Johns Hopkins College.





Supply hyperlink

The Fund Times
ADMINISTRATOR
PROFILE

Posts Carousel

Leave a Comment

Your email address will not be published. Required fields are marked with *

Latest Posts

Top Authors

Most Commented

Featured Videos